Representatives of Dangote Industries Limited, led by Managing Director, Infrastructure and Logistics, Captain Jamil Abubakar, recently engaged with the people of Ode Omi Community in Ogun State as part of ongoing preparations for the proposed Deep Seaport project.
Expected to be the largest seaport in Africa, the project represents a significant investment in infrastructure, trade facilitation, logistics capacity, and long-term economic development.
The engagement provided an opportunity to strengthen dialogue with the host community, share the vision for the project, and reinforce the importance of partnership, inclusion, and shared prosperity as development plans progress.
#DangoteDeepSeaport #InfrastructureDevelopment #CommunityEngagement #DangoteGroup
President @CyrilRamaphosa officially launches the national rollout of Lenacapavir, a new long-acting HIV prevention injection that has the potential to transform HIV prevention and expand access to life-saving healthcare at the Lilian Ngoyi Stadium in Secunda, Mpumalanga.
The President described the rollout as a major step forward in South Africa's HIV response, highlighting the power of science, innovation and partnership to protect lives, prevent new infections and build a healthier future for generations to come.
President Cyril Ramaphosa: On Ebola, South Africa has made a contribution of five million dollars to the Africa Centres for Disease Control and Prevention (AUCDC).
#KBCniYetu
An overlooked personal signal to pay attention to:
The things that are *easy* for you in your work, are often a sign of incredible talent in that area.
Kenyan researcher Professor George Njoroge wins Sh446 million award alongside UK scientist Professor Robert Bristow, for advancing early detection of oesophageal cancer.
Uganda publishes the Bundibugyo Ebolavirus sequence within 4 days of the outbreak announcement. The sequence comes from the virus isolated from an imported case who came for medical treatment in Uganda. It is important to note that there is NO community transmission of the virus so far in Uganda. Well done the team @MinofHealthUG@GovUganda@ICER_Global Thanks to support coming from @AfricaCDC@WHOUganda@WHO
https://t.co/eaQdvz4Dlc?
Had a wonderful Dissemination event for CREATE funded by @NIHRglobal in Accara, Ghana
Collaborative Care Model for people living with cardiometabolic conditions
Wonderful testimonials from our collaborators in Ghana, Kenya & Mozambique
Working with communty assets- changing the lives of people with cardiometabolic conditions
Its been an absolute pleasure coordinating this really important programme of work with @scelee1
The challenge used to be: Is this a person or robot
The challenge now is: Is this a person who's delegated their autonomy to a robot?
The next challenge will be: Which of these person (s)/robot(s) has personhood?
Now before I reply to someone I have to check first that I'm not being baited by an account that spams everyone with AI-generated replies.
Can you write some software to do this check for me @nikitabier?
Every time you get a cancer biopsy, the lab makes a tissue slide that costs about $5. It shows the shape of your cells under a microscope, and every cancer patient already has one on file.
Thereโs a much fancier version of that test called multiplex immunofluorescence (basically a protein-level map showing which immune cells are near your tumor and what theyโre doing). It costs thousands of dollars per sample, takes specialized equipment most hospitals donโt have, and barely scales. But itโs the kind of data oncologists need to figure out whether immunotherapy will actually work for you. Right now, only about 20 to 40% of cancer patients respond to immunotherapy, and one of the biggest reasons is that doctors canโt easily tell whether a tumor is โhotโ (immune cells actively fighting it) or โcoldโ (immune system ignoring it).
Microsoft, Providence Health, and the University of Washington trained an AI to analyze the $5 slide and predict what the expensive test would show across 21 different protein markers. They called it GigaTIME, trained it on 40 million cells in which both the cheap slide and the expensive test coexisted, and then turned it loose on 14,256 real cancer patients across 51 hospitals in 7 US states.
The results landed in Cell, one of the most selective journals in biology. The model generated about 300,000 virtual protein maps covering 24 cancer types and 306 subtypes. It found 1,234 real, verified connections between immune cell behavior, genetic mutations, tumor staging, and patient survival that were previously invisible at this scale. When they tested it against a completely separate database of 10,200 cancer patients, the results matched up almost perfectly (0.88 out of 1.0 agreement).
Nature Methods named spatial proteomics (mapping where specific proteins sit inside your tissue) its Method of the Year in 2024, and specifically cited GigaTIME in a March 2026 update as a model that โdemocratizesโ this kind of analysis. The full model is open-source on Hugging Face. Any cancer research lab with archived biopsy slides, and most of them have thousands, can now run virtual immune profiling without buying a single piece of new equipment.
Wow! Mexico, South Korea & Vietnam were low-income nations just ~40 years ago. Now they're powering breakthroughs in medicine! From poverty to innovation powerhouses. Africa & Global South: With AI + computing power exploding, our leap can be EVEN FASTER. Let's build the future!
Today my X feed is overflowing with actual medical breakthroughs:
๐ฒ๐ฝ Mexican scientists eliminated HPV
๐ช๐ธ Spanish researchers cured prostate cancer in mice
๐ฏ๐ต Japan restored motor function in paralyzed patients via regenerative medicine
๐ฐ๐ท Korean scientists report reversing colon cancer
๐ป๐ณ Vietnamese clinicians show blood cancer can be completely treated
Biomedical science is advancing at an unprecedented, accelerating pace.
A genuinely great day for medicine. ๐งฌ๐